Delivery Order SPE2DR25D2014-SPE2DR26FA2M5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,866.81 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of December 2, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,784.75 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of May 9, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies pharmaceutical...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $2,679.70 for Lidocaine 5% Patch 30S, with an ultimate completion date of December 9, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,554.26 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch in quantities of 30 units. This firm fixed-price contract, issued on January 12, 2026, represents a non-set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,576.14 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with a completion date of January 12, 2026. This is a firm fixed-price delivery order issued without set-aside designation, meaning it was competitively awarded to the vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,358.89 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of December 22, 2025. This is a firm fixed-price, non-competitive delivery order placed under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,437.38 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units under a firm fixed-price contract. The award was competitively procured without set-aside provisions and is scheduled for completion by June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $19,759.87 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of November 13, 2025. The contract employs firm fixed pricing and represents a non-competitive, non-set-aside award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $2,135.94 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units, with a completion date of September 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems....
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $3,199.73 to Amerisourcebergen Drug Corp, a leading pharmaceutical sourcing and distribution company, for the supply of 4564119721 - Lidocaine 5% Patch 30s. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to provide a range of pharmaceutical products and medical supplies to DLA Troop Support Medical...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA2M5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,734.56 to Amerisourcebergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of January 15, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies performance at Amerisourcebergen's Conshohocken, Pennsylvania location. The delivery order is issued under Amerisourcebergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a broad range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill competitive procurement requirements for both specialty and generic medications, vaccines, and medical supplies. This particular delivery order for Lidocaine patches represents a routine pharmaceutical procurement supporting military medical operations and treatment facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 1/13/26 |